A commentary on treatment at random: The ultimate science or the betrayal of Hippocrates?

Journal of Clinical Oncology

Volumn 22, Issue 24, 2004, Pages 5009-5011

  Wieand, Samuel ^a   Murphy, Kate ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; CLINICAL RESEARCH; HUMAN; MEDICAL ETHICS; METHODOLOGY; NOTE; OBSERVATIONAL STUDY; PATIENT CARE; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZATION; STANDARD;

EID: 27644450110     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.09.136     Document Type: Note

References (12)

1. Retsas S: Treatment at random: The ultimate science or the betrayal of Hippocrates? J Clin Oncol 22:10.1200/JCO.2004.01.044
2. Fisher RA: The Design of Experiments (ed 7). Edinburgh, Scotland, Oliverand Boyd, 1971
3. Byar DP: Why data bases should not replace randomized clinical trials. Biometrics 36:337-342, 1980
4. Pocock SJ, Elbourne DR: Randomized trials or observational tribulations? N Engl J Med 342:1907-1909, 2000
5. Omenn GS, Goodman GE, Thornquist MD, et al: Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular medicine. N Engl J Med 334:1150-1155, 1996
6. The Heart Outcomes Prevention Evaluation Study Investigators: Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 342:154-160, 2000
7. Hulley S, Grady D, Bush T, et al: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280:605-613, 1998
8. Writing Group for the Women's Health Initiative Investigators: Risks and benefits of estrogen progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-333, 2002
9. The Women's Health Initiative Steering Committee: Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA 291:1701-1712, 2004
10. Rodenhuis S, Bontenbal M, Beex LVAM, et al: High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer. N Engl J Med 349:7-16, 2003
11. Tallman MS, Gray R, Robert NJ, et al: Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancer. N Engl J Med 349:17-26, 2003
12. Loprinzi CL, Rajkumar SV: Why not start with thalidomide? J Clin Oncol 21:2211-2214, 2003